NIH Selects Dr. Steven Schiff as Director of Fogarty International Center, Associate Director for International Research

National Institutes of Health Director Jay Bhattacharya, M. D, today announced the selection of Steven Schiff, M. D, Ph. D, as the next director of the Fogarty International Center and NIH associate director for international research. The institutional report frames the development in practical terms and ties it to the broader mission or observing effort.

That matters because biology becomes more informative when an observed effect begins to look like a mechanism rather than an isolated pattern. The gap between identifying a correlation in biological data and understanding the causal chain that produces it is routinely underestimated, and the history of biomedical research is populated with associations that collapsed when the mechanism was sought and not found. A result that comes with a proposed mechanism, even a partial one, is more useful than a purely descriptive finding because it generates testable predictions that can narrow the hypothesis space. Schiff began his role on June 4, 2026. Schiff brings nearly 40 years of experience in global health, epidemiology of microbial diseases, and pediatric neurological disorders to NIH,” said Dr.

His groundbreaking work on developing the concept of predictive personalized public health will bring a cutting-edge scientific mind to the NIH leadership team. Kilmarx, M. D, who has been serving as the acting director of FIC since early 2025.” As director of FIC, Schiff will lead NIH’s global health research efforts by supporting.

He will oversee the center’s approximately $95 million annual budget, most of which supports research grants and training programs. Schiff has authored nearly 250 scientific publications spanning neural control engineering, sustainable health engineering, and global health.

He received the NIH Director’s Pioneer and Transformative Awards in 2015 and 2018, respectively, which have enabled him to pursue his interests in the sustainable control of. He is a fellow of the American Association for the Advancement of Science, American College of Surgeons, American Association of Neurological Surgery, American Physical Society.

The broader interest lies in whether the reported effect points toward a real mechanism and not merely a reproducible but unexplained association. Biology has learned from decades of biomarker failures that correlation, even robust correlation, is not a substitute for mechanistic understanding. A pathway that can be traced from molecular interaction to cellular response to organismal phenotype provides a far stronger foundation for intervention than a statistical association discovered in a large dataset, however well the statistics are done.

The Fogarty International Center addresses global health challenges through innovative and collaborative research and training programs and supports and advances the NIH mission. For more information, visit https: //www. fic. nih. gov/.

Because the account originates with NIH News Releases, it functions best as a primary institutional report that is close to the data and operations, not as independent scientific validation. Institutional communications are produced by organizations with legitimate interests in presenting their work in a favorable light, which does not make them unreliable but does make them partial. Details that complicate the narrative, including instrument limitations, unexpected failures and results below projections, tend to be minimized relative to progress messages. Technical documentation and peer-reviewed publications, where they exist, provide the complementary layer that institutional releases cannot substitute.

The next step is to test whether the effect repeats across different methods, cell types, model organisms and experimental conditions. Reproducibility is the first test, but mechanistic dissection is the second, and a result that passes both has a substantially better chance of translating into something clinically or biotechnologically useful. The path from a laboratory finding to an applied outcome typically takes a decade or more, and most findings do not complete it; the current result sits at the beginning of that process.

Source